Reinforce drug product development

Elegent is a spin-off company from Ghent University offering modelling consultancy 
services for the pharmaceutical and food industries.   

We are an interface with academic innovations 
to solve your PAT and process development challenges.

Use the next-generation manufacturing tools to save time in bringing 
pharmaceutical products to the market.  

Contact Us

Elegent is a consultancy firm specializing in assisting companies in implementing Industry 4.0 techniques through the utilization of quantitative data-driven support for drug product development.

At Elegent, we offer three primary services to our clients. First, we provide expertise in formulation and process development for the production of oral solid dosage forms, starting from powder-to-tablet manufacturing. Additionally, we offer consultancy services for the implementation of process analytical technology, focusing on chemometric modelling and its practical applications. Lastly, we offer customised process modelling guidance and deliverables tailored to the specific requirements of our clients.

What sets Elegent apart is our comprehensive range of services, which combine experimental approaches, guidance based on our extensive knowledge in pharmaceutical technology and data science, as well as the development of model-based functionalities. This all-inclusive package can be customized to meet the unique needs of each client, and we provide an initial consultation free of charge to establish familiarity and understanding.

Throughout all our services, Elegent maintains a consistent commitment to delivering applicable and actionable results that align with the specific needs of our clients. We aim to make data science tangible and employ process models that provide direct answers to drug product development inquiries.

Accelerate product development

What are the benefits of working with Elegent? You can modernise and augment your capabilities for drug product development, saving materials, cost and time in the early stages of drug product development, leading to faster launches of new drug products.

Furthermore, integrating digital tools into your workflows can significantly increase efficiency and enhance knowledge acquisition within your organisation. Embracing these digital advancements not only streamlines your current operations but also fosters growth and progress in this direction.

In summary, collaborating with Elegent empowers you to optimise your drug product development, achieve cost and time savings, and capitalise on the newest digital tools. Contact us today for an initial acquaintance an more information.